AAAAAA

   
Results: 1-25 | 26-41 |
Results: 26-41/41

Authors: Collins, LV Tarkowski, A
Citation: Lv. Collins et A. Tarkowski, Animal models of experimental Staphylococcus aureus infection, GRAM-POSITIVE PATHOGENS, 2000, pp. 422-430

Authors: Verdrengh, M Lindberg, FP Ryden, C Tarkowski, A
Citation: M. Verdrengh et al., Integrin-associated protein (IAP)-deficient mice are less susceptible to, developing Staphylococcus aureus-induced arthritis, MICROBES IN, 1(10), 1999, pp. 745-751

Authors: Deng, GM Nilsson, IM Verdrengh, M Collins, LV Tarkowski, A
Citation: Gm. Deng et al., Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis, NAT MED, 5(6), 1999, pp. 702-705

Authors: Almstahl, A Kroneld, U Tarkowski, A Wikstrom, M
Citation: A. Almstahl et al., Oral microbial flora in Sjogren's syndrome, J RHEUMATOL, 26(1), 1999, pp. 110-114

Authors: Ulanova, M Tarkowski, A Hahn-Zoric, M Hanson, LA
Citation: M. Ulanova et al., Participation of CD1 molecules in the presentation of bacterial protein antigens in humans, SC J IMMUN, 50(4), 1999, pp. 387-393

Authors: Sakiniene, E Heyman, B Tarkowski, A
Citation: E. Sakiniene et al., Interaction with complement receptor 1 (CD35) leads to amelioration of sepsis-triggered mortality but aggravation of arthritis during Staphylococcus aureus infection, SC J IMMUN, 50(3), 1999, pp. 250-255

Authors: Tarkowski, E Blennow, K Wallin, A Tarkowski, A
Citation: E. Tarkowski et al., Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia, J CLIN IMM, 19(4), 1999, pp. 223-230

Authors: Tarkowski, E Rosengren, L Blomstrand, C Jensen, C Ekholm, S Tarkowski, A
Citation: E. Tarkowski et al., Intrathecal expression of proteins regulating apoptosis in acute stroke, STROKE, 30(2), 1999, pp. 321-327

Authors: Josefsson, E Tarkowski, A
Citation: E. Josefsson et A. Tarkowski, Staphylococcus aureus-induced inflammation and bone destruction in experimental models of septic arthritis, J PERIOD RE, 34(7), 1999, pp. 387-392

Authors: Nilsson, IM Verdrengh, M Ulrich, RG Bavari, S Tarkowski, A
Citation: Im. Nilsson et al., Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity, J INFEC DIS, 180(4), 1999, pp. 1370-1373

Authors: Hultgren, O Kopf, M Tarkowski, A
Citation: O. Hultgren et al., Outcome of Staphylococcus aureus-triggered sepsis and arthritis in IL-4-deficient mice depends on the genetic background of the host, EUR J IMMUN, 29(8), 1999, pp. 2400-2405

Authors: Verdrengh, M Kum, W Chow, A Tarkowski, A
Citation: M. Verdrengh et al., The effect of site-specific monoclonal antibodies directed to toxic shock syndrome toxin-1 in experimental Staphylococcus aureus arthritis, CLIN EXP IM, 118(2), 1999, pp. 268-270

Authors: Nilsson, N Bremell, T Tarkowski, A Carlsten, H
Citation: N. Nilsson et al., Protective role of NK1.1(+) cells in experimental Staphylococcus aureus arthritis, CLIN EXP IM, 117(1), 1999, pp. 63-69

Authors: Sakiniene, E Bremell, T Tarkowski, A
Citation: E. Sakiniene et al., Complement depletion aggravates Staphylococcus aureus septicaemia and septic arthritis, CLIN EXP IM, 115(1), 1999, pp. 95-102

Authors: Tarkowski, A Sun, JB Holmdahl, R Holmgren, J Czerkinsky, C
Citation: A. Tarkowski et al., Treatment of experimental autoimmune arthritis by nasal administration of a type II collagen-cholera toxoid conjugate vaccine, ARTH RHEUM, 42(8), 1999, pp. 1628-1634

Authors: Bergquist, J Tarkowski, A Ewing, A Ekman, R
Citation: J. Bergquist et al., Catecholaminergic suppression of immunocompetent cells, IMMUNOL TOD, 19(12), 1998, pp. 562-567
Risultati: 1-25 | 26-41 |